edited by Timothy A. Caulfield, Bryn Williams-Jones.
Boston, MA
Springer US
1999
(xiv, 200 pages)
1. Biotechnology: Sovereignty and Sharing --;2. National Policies Influencing Innovation based on Human Genetics --;3. Transformation of a Research Platform into Commercial Products: The Impact of United States Federal Policy on Biotechnology --;4. Intellectual Property Rights and the Human Genome --;5. Making Room: Reintegrating Basic Research, Health Policy, and Ethics into Patent Law --;6. Conflict of Interest and Commercialization of Biomedical Research:What is the Role of Research Ethics Review? --;7. Scientific Journals and Their Authors' Financial Interests: A Pilot Study --;8. The Icelandic Health Sector Database: Legal and Ethical Considerations --;9. Xenotransplantation: Science, Risk and International Regulatory Efforts --;10. Cloning, God, Hitler and Mad Scientists: Arguments Used by the Public in the Cloning Debate on the Internet --;11. Patients' and Professionals' Views on Autonomy, Disability, and 'Discrimination': Results of a 36-Nation Survey --;12. Marketing and Fear Mongering: Time to Try Private Genetic Services? --;Contributors.
The rapid advances made in genetic research and technology over the last few decades have led to a host of important discoveries that have allowed for the detection (and hopefully soon the treatment) of a number of genetic conditions and diseases.
Ethics.
Law.
Philosophy (General)
QH438
.
7
E358
1999
edited by Timothy A. Caulfield, Bryn Williams-Jones.